As a cytokine of the TNF superfamily, it triggers apoptosis in a cell-type-dependent manner, as in CRC [44], in which resistance to the proapoptotic effect of TRAIL increases throughout malignant progression [45,46]. The gene discussed is TNFSF10; the disease is colorectal carcinoma.